Ewertz M, Schou G, Boice J D
Danish Cancer Registry, Institute of Cancer Epidemiology under the Danish Cancer Society, Copenhagen, Denmark.
Eur J Cancer Clin Oncol. 1988 Feb;24(2):189-94. doi: 10.1016/0277-5379(88)90251-9.
The joint effect of risk factors on endometrial cancer was examined by applying general statistical models to the data of a hospital-based case-control study conducted in Copenhagen, Denmark. The analysis included 149 cases of histologically confirmed adenocarcinoma of the endometrium and 154 age-matched controls with cervical cancer. Information on risk factors derived from the medical records. Estrogen use and body mass were found to be the main predictors of endometrial cancer risk. In the model proposed, women who ever used non-contraceptive estrogens had a 10-fold increased risk irrespective of their weight and height. Among non-users of estrogen, the risk of endometrial cancer rose with increasing body mass, the largest showing a five-fold increased risk. These data provide further evidence of the significant role that excess estrogens play, whether exogenous from replacement therapy or endogenous from enhanced androgen conversion, in the etiology of endometrial cancer.
通过将一般统计模型应用于在丹麦哥本哈根进行的一项基于医院的病例对照研究的数据,研究了风险因素对子宫内膜癌的联合影响。该分析纳入了149例经组织学确诊的子宫内膜腺癌病例和154例年龄匹配的宫颈癌对照。风险因素信息来自病历。发现雌激素使用和体重是子宫内膜癌风险的主要预测因素。在所提出的模型中,曾经使用过非避孕雌激素的女性,无论其体重和身高如何,患癌风险增加了10倍。在未使用雌激素的女性中,子宫内膜癌风险随着体重增加而上升,体重增加最多者患癌风险增加了5倍。这些数据进一步证明了无论是来自替代疗法的外源性雌激素还是来自雄激素转化增强的内源性雌激素,在子宫内膜癌病因学中都发挥着重要作用。